By targeting the DNA damage response (“DDR”) in cancer cells, Breakpoint Therapeutics aims to advance to clinical development first-in-class oncology drugs that interfere with DNA repair and replication stress tolerance
pathways. Our mission is to develop drugs that succeed and complement PARP inhibitors and facilitate the cure of therapy resistant cancers.
Location: Germany, Hamburg
Member count: 1-10
Founded date: 2019
Investors 1
| Date | Name | Website |
| - | Taiho Vent... | taihoventu... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 20.06.2023 | Biotech Breakthroughs: Unraveling Germany’s 15 Emerging Biot... | Emergence Therapeutics led by Jack Elands, is a promising biopharmaceutical company dedicated to adv... | eustartup.... |
| 09.10.2021 | Top 10 Healthcare Startups in Germany | The global healthcare market is expected to reach USD 11,908.9 billion by 2022, growing at a CAGR of... | vcbay.news... |